Rubedo Life Sciences Appoints Dr. Frederick Beddingfield III as CEO
11 Nov 2024 //
BUSINESSWIRE
Rubedo Life Sciences Expands in Europe Ahead of Clinical Trial
23 Oct 2024 //
BUSINESSWIRE
Rubedo Life Sciences and Beiersdorf Partner on Cellular Aging Skincare
23 Apr 2024 //
BUSINESSWIRE
Rubedo Closes $40M Series A Led By Khosla, Ahren
22 Apr 2024 //
BUSINESSWIRE
Rubedo pulls in $40M Series Ato advance atopic dermatitis targeting aging cells
22 Apr 2024 //
ENDPTS
Rubedo Life Sciences Presents In Vivo Efficacy Data Targeting Senescence Cells
20 Mar 2023 //
BUSINESSWIRE
Rubedo Life Sciences Awarded $1.45M in Funding From the CIRM
06 Feb 2023 //
BUSINESSWIRE
Rubedo appoints Ali Siam asCBO and Ofir Moreno as SVP of Drug Discovery
01 Aug 2022 //
BUSINESSWIRE
Rubedo Life Sciences Expands Leadership Team with CBO and SVP
01 Aug 2022 //
BUSINESSWIRE
Rubedo Life Sciences Announces Expansion of Scientific Advisory Board
13 Jun 2022 //
BUSINESSWIRE